Xlife Sciences focuses on the performance and growth of life science technologies.
Xlife Sciences AG has raised $5.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2022.
Xlife Sciences AG is headquartered in Zürich, Switzerland.
Xlife Sciences focuses on the performance and growth of life science technologies.
Xlife Sciences AG is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xlife Sciences AG — Funding & Investors." VCBacked, January 26, 2022, https://www.vcbacked.co/company/xlife-sciences-ag. Accessed August 15, 2026.
VCBacked. (2022). Xlife Sciences AG — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/xlife-sciences-ag
{{cite web |title=Xlife Sciences AG — Funding & Investors |url=https://www.vcbacked.co/company/xlife-sciences-ag |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated